Arbormed
PrivateLast Round
Private Placement
Apr 20, 2026
Est. Valuation
$51.16M
Total Funding Raised
$34.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arbormed is a biopharmaceutical company that develops and commercializes therapeutics for diseases with high unmet medical needs, with a focus on rare diseases and complex generics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Pharma Supply Chain, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arbormed Comparables
Compare Arbormed with similar companies based on industry and business-model similarity.
Arbormed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Apr 20, 2026 | ||||
| Series C | Jul 1, 2024 | ||||
| Series B | Nov 1, 2021 | ||||
| Strategic | Jan 1, 2021 | ||||
| Series A | Jan 1, 2020 |
Arbormed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series C |
| Aion Asset Management Co., Ltd. | Series A |
| SBI Investment Korea | Series C, Series A, Series B |
| Hana Securities Co., LTD | Series A |
| Korea Investment & Securities Co., Ltd. | Series C |
| 주식회사 브로드힐벤처스 | Series A |
| 코메스인베스트먼트 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
$1.6M raised in a private placement round.
- Jun 1, 2025
Monthly visitors grew 111% MoM, reaching 2K.
Arbormed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arbormed's valuation, stock price, and market status.